Form D · Pharmaceuticals
Biscayne Pharmaceuticals Inc.
Miami, FL · CIK 0001567845
Offering snapshot reported Nov 4, 2015 · SEC filing
- Reported sold
- $609K Offering amount: $2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 23, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2015 | Initial | $609,000 | No comparison | 3 | SEC filing |
| May 1, 2014 | Initial | $2,628,000 | No comparison | 23 | SEC filing |
| Jan 25, 2013 | Initial | $1,500,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-250669
Source: Form D, filed Nov 4, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Norman Block | Director |
| Stephen D. Collins | Executive |
| Peter Goldstein | Executive |
| Warren Lammert | Director |
| Nair Laxmi | Executive |
| Jack Levine | Director |
| Jared Mendel | Executive |
| Samuel J. Reich | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4770 Biscayne Blvd., Suite 660
Miami, FL, 33137
Miami, FL, 33137